NYU Langone Health (222 East 41st Street) — New York, New York

NYU Langone Health (222 East 41st Street) is a clinical research site located in New York, New York, United States 10017.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Health (222 East 41st Street) has participated in 1 clinical trials.

Therapeutic areas: Stroke.

Sponsors: NYU Langone Health.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health (222 East 41st Street)?

NYU Langone Health (222 East 41st Street) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health (222 East 41st Street) conducted?

NYU Langone Health (222 East 41st Street) has 1 clinical trials on record. Their work covers Stroke.

Is NYU Langone Health (222 East 41st Street) accredited by Crixeo Health?

NYU Langone Health (222 East 41st Street) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health (222 East 41st Street)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.